Fennec Provides Corporate Update and Announces Second Quarter 2017 Results
August 11, 2017 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Aug. 11, 2017) - Fennec Pharmaceuticals Inc. (TSX:FRX) (OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec Announces Results of Annual Meeting
June 28, 2017 12:59 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - June 28, 2017) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) today announced that the nominees listed in the management proxy...
Fennec Announces $7.6 Million Private Placement of Common Shares Led by venBio Select Advisor
June 08, 2017 17:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - June 8, 2017) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) (the "Company" or "Fennec"), a specialty pharmaceutical company...
Fennec Announces Launch of European Named Patient Programme for Sodium Thiosulfate for Pediatric Patients With Standard Risk Hepatoblastoma
May 30, 2017 06:00 ET
|
Fennec Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 30, 2017) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development of...
Fennec Provides Corporate Update and Announces First Quarter 2017 Results
May 12, 2017 06:00 ET
|
Fennec Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 12, 2017) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development of...
Fennec to Present at Pioneers 2017 Joseph Gunnar Conference on May 2, 2017 in New York City
April 27, 2017 06:00 ET
|
Fennec Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - April 27, 2017) - Fennec Pharmaceuticals, Inc. (TSX:FRX)(OTCQB:FENCF), today announced that Rosty Raykov, CEO of Fennec, will be...
Fennec Provides Corporate Update and Announces Fiscal Year Ended December 31, 2016 Financial Results
March 30, 2017 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - March 30, 2017) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec to Present at 19th Annual BIO CEO & Investor Conference
February 09, 2017 17:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Feb. 9, 2017) - Fennec Pharmaceuticals, Inc. (TSX:FRX)(OTCQB:FENCF), today announced that Rosty Raykov, CEO of Fennec, will present...
Fennec Announces the Lancet Oncology Publication of Children's Oncology Group Study of Sodium Thiosulfate
December 01, 2016 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Dec. 1, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX) (OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec Announces Repricing of Warrants
November 15, 2016 17:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Nov. 15, 2016) - Fennec Pharmaceuticals Inc. (the "Company" or "Fennec") (TSX:FRX)(OTCQB:FENCF) announced today that its board of...